Paul is the Business Unit Manager for Cell & Gene Therapy at Fraunhofer IZI in Leipzig. He is responsible for the strategic and financial development of the cell and gene therapy sector, generating new business models and establishing collaborations with partners in this field. Having worked on several EU-funded projects, including AIDPATH, CREATIC and T2EVOLVE, he has established an extensive network within the CAR-T community.